Most cited papers from Novasep (Belgium)

Novasep (Belgium)

What are the most cited papers from Novasep (Belgium)?

The most cited paper from Novasep (Belgium) is "Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults" (Etienne Marc Sokal, Karel Hoppenbrouwers, Corinne Vandermeulen et al., 2007), with 431 citations. Next come "Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults" (181) and "Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up" (75).

Published TypeFieldAccess

Showing 16 of 16 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults Etienne Marc Sokal, Karel Hoppenbrouwers, Corinne Vandermeulen et al. · The Journal of Infectious Diseases Open access	5 Dec 2007	431
2	Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults Michel P. Moutschen, Philippe Léonard, Etienne Marc Sokal et al. · Vaccine	19 Apr 2007	181
3	Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up Valérie Girard, Nicolas-Julian Hilbold, Candy K.S. Ng et al. · Journal of Biotechnology	8 May 2015	75
4	Characterization of Wild-Type Recombinant Bet v 1a as a Candidate Vaccine against Birch Pollen Allergy Thierry Batard, A. Didierlaurent, Henri Chabre et al. · International Archives of Allergy and Immunology	2005	46
5	Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02V-adjuvanted hepatitis B vaccine Murielle Surquin, Christian L. Tielemans, Imre Kulcsár et al. · Kidney International Open access	25 Nov 2009	37
6	Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris Bart W. Faber, Edmond J. Remarque, Clemens H. M. Kocken et al. · Vaccine	18 Sep 2008	34
7	Engineering of non-conventional yeasts for efficient synthesis of macromolecules: the methylotrophic genera Sophie A. Houard, Michel Heinderyckx, Alex Bollen · Biochimie	Nov 2002	34
8	Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative trials Christian L. Tielemans, Jiri Vlasak, Dezider Kosa et al. · Vaccine	17 Dec 2010	32
9	DNA vaccine encoding endosome‐targeted human papillomavirus type 16 E7 protein generates CD4+ T cell‐dependent protection Jean‐Marc Brulet, Frédéric Maudoux, Séverine Thomas et al. · European Journal of Immunology	Feb 2007	27
10	Tissue factor: a mini-review Valéry Daubie, Roland Pochet, Sophie A. Houard et al. · Journal of Tissue Engineering and Regenerative Medicine ReviewOpen access	2007	27
11	Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers Christine Sadorge, Anna Julienne Selbé Ndiaye, Nathalie Beveridge et al. · Vaccine	4 Dec 2007	20
12	Anti-HBs antibody persistence following primary vaccination with an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency Murielle Surquin, Christian L. Tielemans, Joëlle Nortier et al. · Human Vaccines Open access	Sep 2011	17
13	Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults Jiřı́ Beran, Lenka Hobzová, Veronika Wertzova et al. · Human Vaccines Open access	Jul 2010	16
14	Risk Assessment of the Use of Autonomous Parvovirus-Based Vectors Francis Dupont · Current Gene Therapy	Dec 2003	14
15	Integrated Strategy for the Production of Therapeutic Retroviral Vectors Manuel J.T. Carrondo, Amos Panet, Dagmar Wirth et al. · Human Gene Therapy Open access	2 Nov 2010	9
16	La Wallonie entre en scène Clotilde Léger · Biofutur	Oct 2000	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.